Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer

Front Oncol. 2022 Oct 19:12:1035245. doi: 10.3389/fonc.2022.1035245. eCollection 2022.

Authors

Pasquale Pisapia¹, Zhi Li², Cyril Corbet³

Affiliations

¹ Department of Public Health, University of Naples Federico II, Naples, Italy.
² Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, China.
³ Institut de Recherche Expérimentale et Clinique (IREC), Pole of Pharmacology and Therapeutics, Brussels, Belgium.

No abstract available

Keywords: NSCLC; biomarker; lung cancer; molecular; target therapy.

Publication types

Editorial